Artificial intelligence | Medical Devices

Artificial intelligence stories

Artificial intelligence in drug discovery
2023-12-01T09:27:00+00:00
MD2/IVD2: Unravelling AI as a medical device - Insights into the EU AI Act and other global perspectives
2024-11-08T06:56:00+00:00
HM6: Artificial Intelligence – How will AI and machine learning tools transform regulatory practice?
2024-11-08T06:52:00+00:00
HM1: Ensuring regulatory excellence
2024-11-08T06:51:00+00:00
Regulators publish new guidelines for use of AI
2024-10-23T14:27:00+01:00
Breaking barriers: the future of CMC powered by AI
2024-10-11T10:24:00+01:00
AI used to predict candidate antibiotics in radical study
2024-06-14T10:26:00+01:00
RegRapPod − April 2024
2024-04-13T00:05:00+01:00
Unveiling the synergy of AI’s regulatory harmony in shaping the future of biopharmaceutical progress
2024-04-03T12:00:00+01:00
RegRapPod − February 2024
2024-02-20T16:51:00+00:00
Developing a digital people strategy to harness the power of generative AI
2024-02-09T16:30:00+00:00
Sink or swim: the changing tides of device regulation
2024-02-08T00:05:00+00:00
Chemical characterisation: a critical first step for medical device development
2024-02-08T00:05:00+00:00
Overview of medical device regulations in Canada
2024-02-08T00:05:00+00:00
AI meets medtech:
big opportunities
require a
measured approach
2024-02-08T00:05:00+00:00
EU MDR implementation – what is changing for the medical device industry?
2024-02-08T00:05:00+00:00
Device which can detect skin cancer approved by FDA
2024-01-23T11:17:00+00:00
RegRapPod − January 2024
2024-01-15T00:05:00+00:00
Artificial intelligence in drug discovery
2024-01-05T00:05:00+00:00
EMA/HMA publish workplan for the responsible use of AI
2024-01-03T15:19:00+00:00
ICMRA regulators to mark its 10th year at event in Australia
2023-11-10T11:00:00+00:00
FDA to establish Digital Health Advisory Committee
2023-10-31T11:28:00+00:00
Safe use of AI is subject of EMA reflection paper
2023-08-04T11:45:00+01:00
AI-generated drug first to reach Phase II trials
2023-06-30T15:31:00+01:00
NHS to receive £21 million fund for AI diagnostics
2023-06-27T08:41:00+01:00
Translating digitalisation trends into tangible solutions
2022-06-22T15:51:00+01:00

Artificial intelligence stories

Artificial intelligence in drug discovery

MD2/IVD2: Unravelling AI as a medical device - Insights into the EU AI Act and other global perspectives

HM6: Artificial Intelligence – How will AI and machine learning tools transform regulatory practice?

HM1: Ensuring regulatory excellence

Regulators publish new guidelines for use of AI

Breaking barriers: the future of CMC powered by AI

AI used to predict candidate antibiotics in radical study

RegRapPod − April 2024

Unveiling the synergy of AI’s regulatory harmony in shaping the future of biopharmaceutical progress

RegRapPod − February 2024

Developing a digital people strategy to harness the power of generative AI

Sink or swim: the changing tides of device regulation

Chemical characterisation: a critical first step for medical device development

Overview of medical device regulations in Canada

AI meets medtech:
big opportunities
require a
measured approach

EU MDR implementation – what is changing for the medical device industry?

Device which can detect skin cancer approved by FDA

RegRapPod − January 2024

Artificial intelligence in drug discovery

EMA/HMA publish workplan for the responsible use of AI

ICMRA regulators to mark its 10th year at event in Australia

FDA to establish Digital Health Advisory Committee

Safe use of AI is subject of EMA reflection paper

AI-generated drug first to reach Phase II trials

NHS to receive £21 million fund for AI diagnostics

Translating digitalisation trends into tangible solutions

Regulatory Rapporteur